Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Study shows no catheter migration

Interrad Medical : 03 February, 2014  (New Product)
A study on peripherally inserted central catheters shows prime advantage of zero incidences of catheter migration reducing the need for re-insertion
Study shows no catheter migration


Interrad Medical announces a paper published in the January 23 British Journal of Nursing titled, “Peripherally Inserted Central Catheters and Minimising Migration”. The author of the paper is Meinir Hughes from the Velindre Cancer Centre in Cardiff, Wales.



The highlight of the paper states that to date, the hospital team has placed 500 SecurAcath devices. The overwhelming benefit of the device is migration prevention. Not a single catheter has required replacement since their introduction. The paper goes on to emphasize the significant cost savings the SecurAcath has provided at the Velindre Cancer Centre, one of the largest cancer centres in the UK.



In addition, the Company announces the hiring of Paul Blackburn, BSN, MNA, RN, VA-BC as Vice President of Clinical Affairs. Paul has over 30 years of experience in health care in both corporate and clinical roles, including Director of Clinical Education and Marketing during 12 years at Bard Access Systems where he developed a highly successful clinical education program and managed the launch of market leading vascular access technologies. Paul speaks domestically and internationally on vascular access subjects and is the immediate past President of the Association for Vascular Access.



“Paul is a great addition to our executive team. This is an exciting time for our Company and Paul’s extensive experience and deep knowledge in vascular access will strengthen our clinical program as we accelerate SecurAcath commercialization,” commented Joe Goldberger, Interrad Medical President and CEO.



The SecurAcath subcutaneous catheter securement technology has many benefits compared to adhesive devices or sutures. SecurAcath offers a low catheter dislodgement rate which will decrease catheter replacement costs. The SecurAcath increases efficiency by decreasing the time required to secure, maintain and remove catheters. The SecurAcath lasts the life of the catheter and does not need to be replaced weekly. Its design allows for improved catheter site cleaning and minimizes catheter movement which may reduce catheter-related infections. The SecurAcath is also sutureless, therefore, eliminating the potential for costly needle stick injuries that can occur when suturing catheters.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo